Prostate specific membrane antigen targeted ultrasmall manganese ferrite nanoparticles for PET/MR imaging of prostate cancer.
This work demonstrates that combining the inherent MR T1 contrast enhancement capability and favorable pharmacological properties of UMFNPs with PSMA targeting and stable 68Ga labeling yields a highly specific, safe, and quantitative PET/MR nanoplatform, offering substantial promise as a potential clinically translatab...